Lung Cancer News and Research

Latest Lung Cancer News and Research

Biothera reports positive results from Phase 2 clinical trial of Imprime PGG in NSCLC patients

Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.

8 Jan 2014

Cancer statistics 2014 finds steady declines in death rates

The annual cancer statistics report from the American Cancer Society finds steady declines in cancer death rates for the past two decades add up to a 20 percent drop in the overall risk of dying from cancer over that time period.

8 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.

7 Jan 2014

Viewpoints: Rethinking what health insurance should cover; Sen. Johnson suing over congressional health plan; Medicaid's unsung success

The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).

7 Jan 2014

Researchers work on alternative therapy to boost immune system of patients with lung cancer

Research from the National Institute of Respiratory Diseases informs that besides smoking, there are other factors associated to the development of lung cancer such as the smoke from burning lumber and coal, as well as pollutant particles.

7 Jan 2014

ACR supports USPSTF recommendations for CT lung cancer screening in high-risk patients

The American College of Radiology (ACR) supports the United States Preventive Services Task Force (USPSTF) recommendation (Grade B) for low-dose computed tomography (CT) lung cancer screening of adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.

2 Jan 2014

Controlling tobacco marketing may reduce number of smokers by one-third

Tripling taxes on cigarettes around the world would reduce the number of smokers by one-third and prevent 200 million premature deaths from lung cancer and other diseases this century, according to a review published today in the New England Journal of Medicine.

2 Jan 2014

US Task Force recommends lung-cancer screening for high-risk adults

High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine.

30 Dec 2013

USPSTF recommends CT screening for people at high risk for lung cancer

Today, in what has been the culmination of more than two decades of research and advocacy, the United States Preventive Services Task Force issued its final recommendation approving CT screening for those at high risk for lung cancer. The recommendation sets the stage for both public and private insurance coverage and is expected to bring about a dramatic increase in lung cancer survival.

30 Dec 2013

Smoking, diets rich in animal products, alcohol have correlations with cancer incidence rates, says study

A multicountry study just published in Nutrients finds that smoking, diets rich in animal products, and alcohol have the strongest correlations with cancer incidence rates. The cancer incidence rates are from 2008 as assembled by the International Agency for Research on Cancer of the World Health Organization.

28 Dec 2013

Study explores the possibility that smoking behaviors account for highest mortality

Between 1965 and 2004, the distribution of states with the highest mortality changed dramatically. In 1965, the states with the highest mortality (Rhode Island, Alaska, Delaware, Pennsylvania, and New Hampshire) were spread across geographic regions.

28 Dec 2013

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

A deadly, rare type of soft-tissue cancer may be completely eradicated simply by inhibiting a key protein involved in its growth, UT Southwestern Medical Center researchers report.

27 Dec 2013

Researchers complete genomic analysis of cervical cancer in two patient populations

Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations. The study identified recurrent genetic mutations not previously found in cervical cancer, including at least one for which targeted treatments have been approved for other forms of cancer.

25 Dec 2013

Concordia Healthcare acquires Pinnacle Biologics

Concordia Healthcare Corp., an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs, announced today that it has acquired Pinnacle Biologics, Inc., a U.S.-based biopharmaceutical company specializing in legacy pharmaceuticals which have the potential for development as orphan drugs to treat cancer indications in addition to those for which they have previously been approved.

24 Dec 2013

Study reveals that K-Ras gene mutations behave in ways that subvert normal mechanisms of cell death

Cells with a mutation in the gene called K-Ras—found in close to 30 percent of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer—behave in ways that subvert the normal mechanisms of cell death, according to a cell-culture study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.

20 Dec 2013

ATS Foundation, American Lung Association to co-fund $80,000 grant to support HPS research

The American Thoracic Society Foundation and the American Lung Association announced today that they are co-funding an $80,000 grant that will support important research into the mechanisms underlying Hermansky-Pudlak syndrome, a rare inherited disease which affects a number of organs including the lungs.

19 Dec 2013

Genetically targeted drugs used for lung cancer may also have applications in colorectal cancer patients

A University of Colorado Cancer Center study published online ahead of print in the journal Molecular Cancer Research shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers. These results imply that drugs used to target ALK and ROS1 in lung cancer may also have applications in this subset of colorectal cancer patients.

17 Dec 2013

Selenium fails to protect NSCLC patients against second primary tumors

Selenium supplementation does not reduce the risk for second primary tumors in patients with resected non–small-cell lung cancer, researchers say.

17 Dec 2013

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

A phase II study comparing first-line combination pazopanib/pemetrexed chemotherapy with the standard cisplatin/pemetrexed treatment in non-small-cell lung cancer was terminated early owing to an increased frequency of adverse events in the experimental arm.

17 Dec 2013

Lung Cancer News and Research

Latest Lung Cancer News and Research

Biothera reports positive results from Phase 2 clinical trial of Imprime PGG in NSCLC patients

Cancer statistics 2014 finds steady declines in death rates

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

Viewpoints: Rethinking what health insurance should cover; Sen. Johnson suing over congressional health plan; Medicaid's unsung success

Researchers work on alternative therapy to boost immune system of patients with lung cancer

ACR supports USPSTF recommendations for CT lung cancer screening in high-risk patients

Controlling tobacco marketing may reduce number of smokers by one-third

US Task Force recommends lung-cancer screening for high-risk adults

USPSTF recommends CT screening for people at high risk for lung cancer

Smoking, diets rich in animal products, alcohol have correlations with cancer incidence rates, says study

Study explores the possibility that smoking behaviors account for highest mortality

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

Researchers complete genomic analysis of cervical cancer in two patient populations

Concordia Healthcare acquires Pinnacle Biologics

Study reveals that K-Ras gene mutations behave in ways that subvert normal mechanisms of cell death

ATS Foundation, American Lung Association to co-fund $80,000 grant to support HPS research

Genetically targeted drugs used for lung cancer may also have applications in colorectal cancer patients

Selenium fails to protect NSCLC patients against second primary tumors

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in